azomycin has been researched along with bms 181321 in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 23 (92.00) | 18.2507 |
2000's | 2 (8.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kuczynski, B; Patel, B; Rumsey, WL | 1 |
Bauer, A; Eaton, SM; Kuczynski, B; Narra, RK; Nunn, AD; Patel, B; Rumsey, WL; Strauss, HW | 1 |
Kuczynski, BL; Liedtke, AJ; Mulnix, T; Nellis, SH; Nickles, RJ; Nunn, AD; Renstrom, B; Rumsey, WL; Stone, CK | 1 |
Ng, CK; Sinusas, AJ; Soufer, R; Zaret, BL | 1 |
Linder, KE; Patel, B; Rumsey, WL | 1 |
Dione, DP; Heller, EN; Rinker, BD; Shi, CQ; Singer, MJ; Sinusas, AJ; Wackers, FJ; Young, LH; Zaret, BL | 1 |
Eisner, RL; Patterson, RE | 1 |
Linder, KE; Nanjappan, P; Nowotnik, DP; Nunn, AD; Pirro, J; Raju, N; Ramalingam, K; Rumsey, W; Zeng, W | 1 |
Fukuchi, K; Hashimoto, K; Kusuoka, H; Nishimura, T | 1 |
Chan, YW; Cyr, J; Kuczynski, B; Linder, KE; Narra, RK; Nunn, AD; Patel, B; Raju, N; Ramalingam, K; Rumsey, WL | 1 |
Chan, YW; Cyr, JE; Linder, KE; Malley, MF; Nowotnik, DP; Nunn, AD | 1 |
Cyr, JE; Narra, RK; Raju, N; Rumsey, WL | 1 |
Bauer, A; Chan, YW; Cyr, JE; Di Rocco, RJ; Kuczynski, BL; Linder, KE; Narra, RK; Pirro, JP; Raju, N; Ramalingam, K | 1 |
Johnson, G; Nguyen, KN; Okada, RD; Strauss, HW | 1 |
Ballinger, JR; Kee, JW; Rauth, AM | 1 |
Ballinger, JR; Cowan, DS; Melo, T; Park, L; Rauth, AM | 1 |
Berman, M; Carter, E; Fischman, AJ; Gewirtz, H; Mirecki, F; Nunn, A; Southern, J; Strauss, HW | 1 |
Fujiwara, T; Fukuchi, K; Kusuoka, H; Nishimura, T; Watanabe, Y | 2 |
Bauer, AA; Belnavis, L; Chan, YW; Di Rocco, RJ; Kuczynski, BL; Linder, KE; Narra, RK; Nowotnik, DP; Nunn, AD; Pirro, JP | 1 |
Ballinger, JR; Hua, HA; Melo, T; Rauth, AM | 1 |
Leppo, JA; Reinhardt, CP; Weinstein, H | 1 |
Sinusas, AJ | 1 |
Ballinger, JR; Duncan, J; Melo, T; Rauth, AM | 1 |
Banerjee, S; Mallia, MB; Mathur, A; Sarma, HD; Subramanian, S; Venkatesh, M | 1 |
1 review(s) available for azomycin and bms 181321
Article | Year |
---|---|
The potential for myocardial imaging with hypoxia markers.
Topics: Animals; Cell Hypoxia; Heart; Humans; Misonidazole; Myocardial Stunning; Nitroimidazoles; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals | 1999 |
24 other study(ies) available for azomycin and bms 181321
Article | Year |
---|---|
Detecting hypoxia in heart using phosphorescence quenching and 99mtechnetium-nitroimidazoles.
Topics: Animals; Cardiomyopathies; Disease Models, Animal; Dogs; Hypoxia; Luminescent Measurements; Myocardial Ischemia; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Oxygen; Radionuclide Imaging | 1994 |
SPECT imaging of ischemic myocardium using a technetium-99m-nitroimidazole ligand.
Topics: Animals; Autoradiography; Dogs; Heart; Image Processing, Computer-Assisted; Myocardial Ischemia; Nitroimidazoles; Organotechnetium Compounds; Time Factors; Tomography, Emission-Computed, Single-Photon | 1995 |
Myocardial kinetics of a putative hypoxic tissue marker, 99mTc-labeled nitroimidazole (BMS-181321), after regional ischemia and reperfusion.
Topics: Animals; Coronary Circulation; Heart; Microspheres; Myocardial Ischemia; Myocardial Reperfusion; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Oxygen Consumption; Radionuclide Imaging; Swine; Time Factors | 1995 |
Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia.
Topics: Animals; Cell Hypoxia; Heart; Male; Myocardial Ischemia; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Oxygen Consumption; Perfusion; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Sodium Pertechnetate Tc 99m; Technetium Tc 99m Pentetate; Time Factors | 1995 |
Effect of graded hypoxia on retention of technetium-99m-nitroheterocycle in perfused rat heart.
Topics: Animals; Cell Hypoxia; Heart; Male; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Oxygen Consumption; Perfusion; Radionuclide Imaging; Rats; Rats, Sprague-Dawley | 1995 |
Technetium-99m-nitroimidazole (BMS181321): a positive imaging agent for detecting myocardial ischemia.
Topics: Animals; Coronary Circulation; Dogs; Heart; Lactates; Lactic Acid; Myocardial Ischemia; Nitroimidazoles; Organotechnetium Compounds; Oxygen Consumption; Tomography, Emission-Computed, Single-Photon | 1995 |
Value of objective assessment of new radiopharmaceuticals.
Topics: Animals; Coronary Circulation; Dogs; Heart; Myocardial Ischemia; Nitroimidazoles; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon | 1995 |
The synthesis and in vitro evaluation of a 99mtechnetium-nitroimidazole complex based on a bis(amine-phenol) ligand: comparison to BMS-181321.
Topics: Animals; Cattle; Cell Hypoxia; Cell Membrane Permeability; Endothelium, Vascular; In Vitro Techniques; Male; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Rats; Rats, Sprague-Dawley | 1994 |
Kinetics of a putative hypoxic tissue marker, technetium-99m-nitroimidazole (BMS181321), in normoxic, hypoxic, ischemic and stunned myocardium.
Topics: Animals; Female; Heart; Myocardial Ischemia; Myocardial Stunning; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Oximes; Oxygen Consumption; Perfusion; Radionuclide Imaging; Rats; Technetium Tc 99m Exametazime | 1994 |
Potential of nitroimidazoles as markers of hypoxia in heart.
Topics: Animals; Biomarkers; Dogs; Hypoxia; In Vitro Techniques; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Oxygen Consumption; Rats; Rats, Sprague-Dawley | 1994 |
TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Topics: Chromatography, High Pressure Liquid; Crystallization; Crystallography, X-Ray; Dimethylformamide; Electrochemistry; Hypoxia; Kinetics; Magnetic Resonance Spectroscopy; Molecular Structure; Nitroimidazoles; Organotechnetium Compounds; Radionuclide Imaging; Stereoisomerism; Xanthine Oxidase | 1994 |
A novel [99m]technetium-labeled nitroheterocycle capable of identification of hypoxia in heart.
Topics: Animals; Heart; Hypoxia; Male; Mitochondria, Heart; Molecular Structure; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Technetium | 1993 |
Imaging ischemic tissue at risk of infarction during stroke.
Topics: Animals; Autoradiography; Blood-Brain Barrier; Brain; Brain Ischemia; Cerebral Infarction; Cerebrovascular Disorders; Male; Nitroimidazoles; Organotechnetium Compounds; Rats; Rats, Inbred SHR; Risk Factors; Tomography, Emission-Computed, Single-Photon | 1993 |
Effects of low flow and hypoxia on myocardial retention of technetium-99m BMS181321.
Topics: Animals; Hypoxia; Myocardial Ischemia; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Rats; Technetium; Time Factors | 1996 |
In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia.
Topics: Animals; Cell Hypoxia; CHO Cells; Cricetinae; Drug Evaluation, Preclinical; In Vitro Techniques; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organotechnetium Compounds; Oxygen; Radionuclide Imaging; Technetium; Tissue Distribution; Tumor Cells, Cultured | 1996 |
BMS181321 accumulation in rodent and human cells: the role of P-glycoprotein.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Hypoxia; CHO Cells; Cricetinae; Drug Resistance; Humans; Neoplasms; Nitroimidazoles; Organotechnetium Compounds; Rats | 1996 |
Myocardial adaptation during and after sustained, demand-induced ischemia. Observations in closed-chest, domestic swine.
Topics: Animals; Blood Pressure; Coronary Circulation; Coronary Disease; Creatine Kinase; Heart; Heart Rate; Hemodynamics; Lactates; Myocardial Ischemia; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Oxygen Consumption; Radionuclide Imaging; Stress, Physiological; Swine; Time Factors | 1996 |
Ischemic and reperfused myocardium detected with technetium-99m-nitroimidazole.
Topics: Animals; Antipyrine; Coronary Circulation; Female; Iodine Radioisotopes; Myocardial Ischemia; Myocardial Stunning; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Radionuclide Imaging; Rats; Rats, Sprague-Dawley; Technetium; Time Factors | 1996 |
Delineation of the border zone of ischemic rabbit myocardium by a technetium-labeled nitroimidazole.
Topics: Animals; Antimetabolites; Autoradiography; Deoxyglucose; Heart; Hemodynamics; Image Processing, Computer-Assisted; Male; Misonidazole; Myocardial Ischemia; Nitroimidazoles; Organotechnetium Compounds; Rabbits; Radiation-Sensitizing Agents; Radionuclide Imaging; Radiopharmaceuticals | 1997 |
Modifying the in vitro accumulation of BMS181321, a technetium-99m-nitroimidazole, with unlabelled nitroaromatics.
Topics: Animals; Cell Hypoxia; CHO Cells; Cricetinae; Electrons; Nitroimidazoles; Organotechnetium Compounds; Radiopharmaceuticals; Tissue Distribution | 1997 |
Contribution of hypoxia to the development of cardiomyopathy in hamsters.
Topics: Animals; Antipyrine; Autoradiography; Cardiomyopathy, Dilated; Cricetinae; Hypoxia; Iodine Radioisotopes; Mesocricetus; Myocardium; Nitroimidazoles; Organotechnetium Compounds | 1997 |
Direct detection of regional myocardial ischemia with technetium-99m nitroimidazole in rabbits.
Topics: Animals; Autoradiography; Coronary Circulation; Fluoresceins; Heart; Myocardial Ischemia; Myocardium; Nitroimidazoles; Organotechnetium Compounds; Photography; Rabbits; Radionuclide Imaging; Time Factors; Tissue Survival | 1998 |
BRU59-21, a second-generation 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors.
Topics: Animals; Cell Hypoxia; CHO Cells; Cricetinae; Female; Imidazoles; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2000 |
A novel [99mTc[triple bond]N]2+ complex of metronidazole xanthate as a potential agent for targeting hypoxia.
Topics: Animals; Hypoxia; Imidazoles; Ligands; Metronidazole; Mice; Molecular Structure; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Organotechnetium Compounds; Radionuclide Imaging; Radiopharmaceuticals; Structure-Activity Relationship; Time Factors; Tissue Distribution | 2005 |